PTPA and central nervous system cancer: While, in agreement with our finding, 2AAA, a subunit of PP2A acting as a tumor-suppressor, is inactivated or dysregulated in about 60% of GBM patients [108], CLIC1 is overexpressed in several solid tumors including gliomas (reviewed [109]).